Healthium’s product portfolio focusses on advanced surgery, urology and arthroscopy products covering 52,000 stock keeping units
BANGALORE, Oct 27 (The CONNECT) – Surgical care global firm Healthium Medtech Limited has announced the launch of TRUSHIELD NXT surgical wound dressing, adding to its portfolio of patented products in the wound care and infection prevention segments.
TRUSHIELD™ NXT combines the advantages of a 3D hydrocellular substrate and patented infection prevention technology to offer a complete wound care system that provides 360-degree wound protection. It provides exudate and moisture management, while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism. It has patents in the U.S, Europe and India.
The announcement comes after Healthium’s acquisition of CareNow Medical last month. As of July 31, 2021, the company has 21 patents in India and 11 patents in the United States, and a further 22 and 6 patent applications pending approval in India and US, respectively. With the acquisition of CareNow, the company has acquired an additional portfolio of one patent each in India, US and Europe and one patent application pending approval in India.
Anish Bafna, CEO and MD, Healthium Medtech, said, aligned to the company’s vision, TRUSHIELD NXT is manufactured to high quality standards at the US FDA registered plant. “With our sales network reaching 90% of districts in India with secondary healthcare facilities catering to 40,000 surgeons across 18,000 hospitals, we look to offering wider choices to our customers and delivering better standards in patient care, with innovative and quality products.”
The advanced wound care market expected to grow at a CAGR of 8.8%. Dominated by traditional wound dressing such as cotton gauze, the advanced wound dressing category has lagged in penetration because of high pricing of products and limited availability. TRUSHIELD™ NXT is non- adherent (does not stick to the wound and can be easily removed) and water proof with exudate management ability when compared to traditional wound dressing and reduces the need to repeatedly change dressings, thereby reducing costs
In addition to wound care, Healthium’s current product portfolio focusses on advanced surgery, urology and arthroscopy products covering 52,000 stock keeping units.
Dr. Ashok Moharana, Chief Medical Officer, Healthium Medtech said “A successful surgery is complemented by a well- healed wound. TRUSHIELD NXT surgical wound dressing, enables healing through exudate and moisture management ability while providing infection control with a patented technology that continuously inhibits growth of pathogen with a 99.99% kill rate against a broad spectrum of pathogen. The dressing is water-proof and does not adhere to the wound, for a trauma- less removal. We believe that with this new technology and our access, we will be able to benefit patients globally.”
As of fiscal 2021, Healthium is India’s largest independent medical device company and second-largest company overall, in the surgical consumables market. In the non-captive surgical needles segment, it is the largest manufacturer globally, by volume and the third-largest company overall in urology collection devices market in the U.K, as on 31st March,2021. As of fiscal 2021, one in five surgeries conducted globally uses a Healthium product.